Show simple item record

dc.contributor.authorJohnson, Jeremy J.
dc.date.accessioned2012-03-09T20:59:12Z
dc.date.available2012-03-09T20:59:12Z
dc.date.issued2011-06-01
dc.identifier.bibliographicCitationJohnson, J. J. 2011. Carnosol: A Promising Anti-cancer and Anti-inflammatory Agent. Cancer Letters, 305(1): 1-7. DOI: 10.1016/j.canlet.2011.02.005en
dc.identifier.issn0304-3835
dc.identifier.otherDOI: 10.1016/j.canlet.2011.02.005
dc.identifier.urihttp://hdl.handle.net/10027/8190
dc.descriptionNOTICE: this is the author’s version of a work that was accepted for publication in Cancer Letters. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Cancer Letters, Vol 305, Issue 1, June 1, 2011. DOI: 10.1016/j.canlet.2011.02.005. The original publication is available at www.elsevier.com.en
dc.description.abstractThe Mediterranean diet and more specifically certain meats, fruits, vegetables, and olive oil found in certain parts of the Mediterranean region have been associated with a decreased cardiovascular and diabetes risk. More recently, several population based studies have observed with these lifestyle choices have reported an overall reduced risk for several cancers. One study in particular observed an inverse relationship between consumption of Mediterranean herbs such as rosemary, sage, parsley, and oregano with lung cancer. In light of these findings there is a need to explore and identify the anti-cancer properties of these medicinal herbs and to identify the phytochemicals therein. One agent in particular, carnosol, has been evaluated for anti-cancer property in prostate, breast, skin, leukemia, and colon cancer with promising results. These studies have provided evidence that carnosol targets multiple deregulated pathways associated with inflammation and cancer that include nuclear factor kappa B (NFκB), apoptotic related proteins, phosphatidylinositol-3-kinase (PI3 K)/Akt, androgen and estrogen receptors, as well as molecular targets. In addition, carnosol appears to be well tolerated in that it has a selective toxicity towards cancer cells versus non-tumorigenic cells and is well tolerated when administered to animals. This mini-review reports on the pre-clinical studies that have been performed to date with carnosol describing mechanistic, efficacy, and safety/tolerability studies as a cancer chemoprevention and anti-cancer agent.en
dc.description.sponsorshipThe original work that was performed with carnosol and prostate cancer was supported by NIH 1KL2RR025012 and K12 RR023268.en
dc.language.isoen_USen
dc.publisherElsevieren
dc.subjectcarnasolen
dc.subjectmediterranean dieten
dc.titleCarnosol: A Promising Anti-Cancer and Anti-Inflammatory Agenten
dc.typeArticleen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record